In compliance with section 17(b) of the Securities Act, we are disclosing that Skye Bioscience, Inc. (OTC: SKYE) is a client of TraDigital Marketing Group, Inc. Skye Bioscience, Inc. has a 2 month agreement in place, dated November 17, 2023 – January 15, 2024 to compensate TraDigital Marketing Group, Inc. a cash retainer of one hundred ninety-five thousand dollars ($195,000) for publicly disseminating information about Skye Bioscience, Inc. via website, email, and SMS.  

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.